In this context, a dibenzazepine derivate has been described as a potent GPR4 antagonist that reduced mortality in a mouse myocardial infarction model in which mice were subjected to permanent ligation of the left anterior descending coronary [66]. The gene discussed is GPR4; the disease is myocardial infarction.